Current through Public Act 171 of the 2024 Legislative Session
Section 333.7218 - Schedule 4; controlled substances included(1) The following controlled substances are included in schedule 4: (a) Any material, compound, mixture, or preparation containing any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation: Barbital | Flurazepam |
Chloral Betaine | Lorazepam |
Chloral Hydrate | Mebutamate |
Chlordiazepoxide | Meprobamate |
Clonazepam | Methohexital |
Clorazepate | Methylphenobarbital |
Dextropropoxyphene | Oxazepam |
Diazepam | Paraldehyde |
Ethchlorvynol | Petrichloral |
Ethinamate | Phenobarbital |
Flunitrazepam | Prazepam |
(b) Any material, compound, mixture, or preparation containing any quantity of the following substances having a potential for abuse associated with an effect on the central nervous system, including their salts, optical, positional, or geometric isomers, and salts of the isomers if the existence of the salts, isomers, and salts of isomers is possible. Fenfluramine
(c) Any material, compound, mixture, or preparation containing any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system, including their salts, optical, positional, or geometric isomers, and salts of the isomers if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation. Diethylpropion
Phentermine
Pemoline, including organometallic complexes and chelates of pemoline.
Cathine
Some trade and other names:
d-norpseudoephedrine
(2) The administrator may except by rule any compound, mixture or preparation containing any substance listed in subsection (1) from the application of all or any part of this article if the compound, mixture or preparation contains 1 or more active medicinal ingredients not having a depressant or stimulant effect on the central nervous system and if the admixtures are in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances having a depressant or stimulant effect on the central nervous system.Amended by 2010, Act 171,s 2, eff. 10/1/2010.1978, Act 368, Eff. 9/30/1978 ;--Am. 1998, Act 319, Eff. 10/1/1998.